Acinetobacter baumannii at a Tertiary-Care Teaching Hospital in Jerusalem, Israel
Open Access
- 1 January 2001
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 39 (1) , 389-391
- https://doi.org/10.1128/jcm.39.1.389-391.2001
Abstract
In a retrospective 10-year analysis of 3,536 patient-unique isolates, Acinetobacter baumannii imipenem susceptibility declined from 98.1 (1990) to 64.1% (2000), and ciprofloxacin susceptibility decreased from 50.5 to 13.1%. Imipenem median zone diameters decreased from 27.7 (1997) to 18.8 mm (2000). No outbreaks were detected. Two clusters were identified for 41 strains genotyped by pulsed-field gel electrophoresis, but imipenem resistance was not clonal.Keywords
This publication has 7 references indexed in Scilit:
- Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2The Lancet, 1998
- Surveillance of Antimicrobial Resistance: The WHONET ProgramClinical Infectious Diseases, 1997
- Imipenem resistance among Acinetobacter baumannii: association with reduced expression of a 33–36 kDa outer membrane proteinJournal of Antimicrobial Chemotherapy, 1996
- Outbreak caused by two multi-resistant Acinetobacter baumannii clones in a burns unit: emergence of resistance to imipenemJournal of Hospital Infection, 1995
- Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactamThe Lancet, 1994
- Antimicrobial susceptibility of Acinetobacter speciesAntimicrobial Agents and Chemotherapy, 1993
- Imipenem Resistance in Acinetobacter baumanii Is Due to Altered Penicillin-Binding ProteinsChemotherapy, 1991